© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Evolent Health, Inc. (EVH) shows an Average True Range (ATR) of 0.26 and an Enterprise Value of 3.83B. Its average trading volume over the past 3 months is 3.61M, indicating liquidity. These fundamental metrics provide insight into EVH's underlying financial health and market activity.
Evolent Health, Inc. (EVH) technical indicators as of December 23, 2025: the SMA 20 is -0.42%, SMA 50 at -24.6%, and SMA 200 at -52.02%. The RSI 14 value is 37, suggesting its current momentum. These technical analysis signals help assess EVH's price trends and potential future movements.
Evolent Health, Inc. (EVH) stock performance overview as of December 23, 2025: The 52-week high is $12.98 (currently -69.03% below), and the 52-week low is $3.49 (currently 15.02% above). Over the past year, EVH's performance is -63.78%, compared to the S&P 500's 12.87% change.
According to market data, Evolent Health, Inc. (EVH) stock's recent performance metrics show that over the last month, EVH is 13.56%, with a Year-to-Date (YTD) performance of -64.27%. Over the past year, the stock has seen a -63.78% change. These figures summarize EVH's price movements across various periods, reflecting its historical returns.
According to current financial data, EVH stock's P/E (TTM) ratio is -3.39, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for EVH, including P/S (0.29), P/B (0.54), and P/FCF (-6.69), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.